These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 18797274)

  • 1. Current management of overactive bladder.
    Cartwright R; Renganathan A; Cardozo L
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):489-95. PubMed ID: 18797274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overactive bladder: an update.
    Hashim H; Abrams P
    Curr Opin Urol; 2007 Jul; 17(4):231-6. PubMed ID: 17558264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in the pharmacotherapy of the overactive bladder.
    Sellers DJ; McKay N
    Curr Opin Urol; 2007 Jul; 17(4):223-30. PubMed ID: 17558263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
    Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z
    J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].
    Shimada M; Inoue K; Okumura T; Aoki S; Ogawa Y; Matsubara E; Maeda T; Ogawa Y; Sasaki H
    Hinyokika Kiyo; 2011 Jan; 57(1):1-6. PubMed ID: 21304252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anticholinergic therapy in men.
    Bauer R; Kaufman R; Mian BM
    Can J Urol; 2008 Dec; 15(6):4359-62. PubMed ID: 19046488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urgency assessment in the evaluation of overactive bladder (OAB).
    Starkman JS; Dmochowski RR
    Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticholinergic drugs in overactive bladder].
    Muhlstein J; Deval B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):90-6. PubMed ID: 18178506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry.
    Mahajan ST; Patel PB; Marrie RA
    J Urol; 2010 Apr; 183(4):1432-7. PubMed ID: 20171697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence.
    Andersson KE; Chapple CR; Cardozo L; Cruz F; Hashim H; Michel MC; Tannenbaum C; Wein AJ
    Curr Opin Urol; 2009 Jul; 19(4):380-94. PubMed ID: 19448545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
    Nordling J
    Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical practice. Idiopathic urgency urinary incontinence.
    Nygaard I
    N Engl J Med; 2010 Sep; 363(12):1156-62. PubMed ID: 20843250
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].
    Goepel M; Schultz-Lampel D
    Urologe A; 2011 Jul; 50(7):802-5. PubMed ID: 21681456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.